Best Drug Delivery Companies in South Korea
The 35 best Drug Delivery companies in South Korea in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: QuadMedicine.
- Rapid Drug Delivery Solution: Enhance Pharmacy’s Services With Mobile
- Global Drug Delivery Market Up $6.3B in 2020 – Growth Driven by COVID-
Ranked: Best Drug Delivery companies in South Korea
| # | Company | Disclosed funding | Last round | Stage | Founder | Founded | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | QuadMedicine Provider of patch for vaccine delivery | $12M | 52 mo ago | Public | Seung-Ki Baek CEO | 2016 | jQueryGoogle WorkspaceGoDaddy+1 | 38 patents Transdermal microneedle patches for combined drug delivery, thermal therapy, and fluid sensing | — |
| 2 | SN BioScience Developer of a nanoparticle-based drug-delivery system for cancer treatment | $4M | 92 mo ago | Series A | — | 2017 | DreamWeaverPHPApache HTTP Server+4 | 540 patents Patents concentrated in health & consumer products | — |
| 3 | LabInCube Developer drug-releasing medical devices and medicines 37Moat top 32%Patents top 34%Innovation top 40%Funding top 43% All 7 signals ▾Moattop 32% Patentstop 34% Innovationtop 40% Fundingtop 43% Talentbottom 49% Globalbottom 40% Marketbottom 37% Moat: Editorial + unicorn rating 4/10 · IP moat: 22 patents Patents: 22 patents matched (strict assignee match) · 22 filings since 2022 vs 0 in 2017-21 rank vs industry peers · Fliar Intelligence Index 37/100 | $4M | 6 mo ago | Series B | Kyeongmin Choi CEO | 2021 | — | 22 patents Porous biopolymer particles for controlled release in cosmetics, drug delivery, and VOC adsorption | — |
| 4 | Medihub Manufacturer of anaesthetic injection system | — | 99 mo ago | Seed | Maro Yeom CEO | 2013 | — | 40 patents Patents concentrated in health & consumer products | — |
| 5 | Femtobiomed Developing an intracellular delivery platform for cell therapeutics | — | 102 mo ago | Public | Sanghyun Lee Founder & CEO | 2016 | — | 24 patents Cell transfection devices for intracellular delivery and diffusion-based liquid fat quantification | — |
| 6 | Raphas Developer of microneedle technology for cosmetics and medical applications | — | 126 mo ago | Public | — | 2006 | — | 139 patents Microneedle-based transdermal patches for dermatological drug delivery and UV protection | — |
| 7 | AULBIO Provider of microsphere based drug delivery system | — | — | Funding Raised | Taekun An CEO | 2018 | — | 28 patents Controlled-release microsphere formulations for peptide and small-molecule therapeutics | — |
| 8 | Biocinetics Developing nanoformulation for multiple disease treatments | — | — | Funding Raised | Gab-Shik Kim CEO | 2004 | — | — | — |
Top 6 Drug Delivery companies in South Korea
#1
Series B · Cheongju-si, Chungcheongbuk-do · founded 2021$3.8Mraised▾
Developer drug-releasing medical devices and medicines. The company has developed the InCube technology, which combines molecular spacing and sustained release techniques to minimize substance degradation and achieve controlled drug release. It create a medical device that can selectively release drugs over extended periods, promoting comfortable and healthy living.
- Mar 2026Series B$9.9M
- Apr 2024Series A$3.8M
#2
Public · Seongnam-si, Gyeonggi-do · founded 2016 · 49 employees$11.7Mraised▾
Provider of patch for vaccine delivery
- May 2022Series C$11.7M
- Nov 2021Seed—
- Jan 2020Seed—
- Series B—
#3
Series A · Seoul, Seoul · founded 2017 · 24 employees$4.4Mraised▾
Developer of a nanoparticle-based drug-delivery system for cancer treatment. The company has developed SN-101 double core-shell micelle technology for the delivery of poorly soluble drugs. The platform is used for the delivery of lyophilized IV formulation containing SN-38 which is an active metabolite of the prodrug IRINOTECAN used for multiple cancer treatment.
- Jan 2019Series A$4.4M
#4
Seed · Gunpo si, Gyeonggi do · founded 2013 · 22 employees—raised▾
Medihub manufactures anesthetic injection systems. The products are I-Ject, I-Ject IN, and I-Ject pro. I-Ject is a wireless digital anesthetic injection system. I-Ject IN dental chair built-in wired digital automatic anesthetic injection system. I-Ject pro is an injector able to inject fixed volume at a constant speed.
- 2018Seed—
#5
Public · Seongnam-si, Gyeonggi-do · founded 2016 · 14 employees—raised▾
FEMTOBIOMED is developing an intracellular delivery platform for cell therapeutics. Its CELLSHOT is the patented technology platform provides cell therapeutics and cell biology research for cancer treatments. It also has other patented technology such as the Viscosity measurement method, Corneal processing equipment, and SMART DROP among others.
- Mar 2018Series A—
#6
Public · Seoul, Seoul · founded 2006 · 105 employees—raised▾
Developer of microneedle technology for cosmetics and medical applications. This company manufactures microneedles for transdermal drug delivery and produces cosmetic and food products utilizing this technology. The company holds various certifications and approvals for its products in multiple regions. Its offerings include a cosmetic brand featuring microneedle technologies and a brand of health-focused food products.
- Mar 2016Seed—
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Drug Delivery coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Drug Discovery is moving in South Korea
A read on the academic research around Drug Discovery — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 1,026 South Korea-affiliated papers.
- Ministry of Education92
- Seoul National University79
- Yonsei University59
- Korea University54
- Korea Advanced Institute of Science and Technology50
- Computational biology5→77
- Chemical space4→43
- Virtual screening2→37
- Pharmacology2→25
- Bioinformatics2→24
- Computational biology6→83
- Virtual screening1→69
- Docking (animal)2→57
- Pharmacology4→39
- Bioinformatics1→29
- Disease1→15
- Computational biology3→13
- Pharmacology2→12
- Bioinformatics3→9
- Cancer1→4
Where drug discovery is researched across South Korea
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Who's filing drug discovery patents in South Korea
South Korea drug discovery patent filing is accelerating — 133,215 filings from 8,000 assignees (2016–2025), led by LG Chemical, Samsung, Amorepacific; annual filings 10080→13976.
- LG Chemical7571
- Samsung6868
- Amorepacific6095
- Hanmi Pharm IND3162
- LG Household & Health CARE2882
- Seoul NAT UNIV R&DB Foundation2349
- Korea INST SCI & TECH2326
- UNIV Korea RES & BUS Found2019
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.